Skip to content

Prilocaine

Published: July 26, 2026Updated: July 26, 2026

Prilocaine is a local anesthetic medication frequently combined with lidocaine in topical formulations to provide temporary numbness of the skin. It is primarily used to reduce pain and discomfort associated with minor procedures, needle insertions, and superficial skin treatments. This medication works by blocking nerve signals in the treated area, making it a common choice for both medical and cosmetic applications.

Quick summary

Prilocaine is a topical local anesthetic used to numb the skin before painful procedures.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 26, 2026Editorial policy

Key facts at a glance

ATC
N01BB04
RxNorm
8686
Generic
Prilocaine
Class
atc-n01
Brands
Citanest, Relador, Citanest Forte, Oraqix
Availability
rx
Lactation
unknown
Routes
topical
Forms
solution, cream
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
500mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
250mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
400mg daily
Maximum
consult physician
Frequency
once daily
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Single dose exceeding 1000mg (approximately 10-12 mg/kg) may cause serious systemic toxicity
Chronic overdose: Repeated or cumulative doses exceeding 400-600mg within the recommended time period
Immediate actions
Secure airway, provide oxygen, establish IV access, monitor cardiac function, treat seizures, consider lipid emulsion therapy
Antidote
Methylene blue (for methemoglobinemia)(Effective for methemoglobinemia; supportive care and ACLS for cardiac toxicity)
Poison Control: 1-800-222-1222

Special Populations

8 groups
⚠

pregnancy

first trimester
caution
FDA Category
B
Dose Adjustment

use lowest effective dose

Key Recommendations

avoid use during pregnancy unless benefits clearly outweigh risks

Monitor

regular fetal monitoring recommended

Use with caution and monitor for adverse effects.

⚠

pregnancy

second trimester
caution
FDA Category
B
Dose Adjustment

use lowest effective dose

Key Recommendations

use only when benefits outweigh potential risks

Monitor

standard prenatal monitoring

Use with caution and monitor for adverse effects.

✓

lactation

breastfeeding
safe
FDA Category
N
Dose Adjustment

no adjustment needed

Key Recommendations

compatible with breastfeeding

Monitor

none required

⚠

pediatric_age

children 2 12 years
caution
FDA Category
B
Dose Adjustment

weight-based dosing required max 5mg/kg

Key Recommendations

use with caution due to risk of methemoglobinemia especially in younger children

Monitor

observe for signs of methemoglobinemia cyanosis

Use with caution and monitor for adverse effects.

⚠

geriatric

over 65 years
caution
FDA Category
B
Dose Adjustment

reduce dose by 25-50%

Key Recommendations

use lower doses due to increased sensitivity and reduced hepatic metabolism

Monitor

monitor cardiovascular and respiratory status

Use with caution and monitor for adverse effects.

⚠

renal_impairment

moderate to severe
caution
FDA Category
B
Dose Adjustment

reduce dose and extend dosing interval

Key Recommendations

use with caution in severe renal impairment monitor for accumulation

Monitor

monitor renal function and for signs of toxicity

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

mild to moderate
caution
FDA Category
B
Dose Adjustment

reduce dose by 25-50%

Key Recommendations

use with caution due to reduced hepatic metabolism

Monitor

monitor for signs of systemic toxicity

Use with caution and monitor for adverse effects.

✗

hepatic_impairment

severe
unsafe
FDA Category
B
Dose Adjustment

avoid or use extremely reduced doses

Key Recommendations

not recommended in severe hepatic impairment due to significantly reduced metabolism

Monitor

close monitoring for toxicity required

Use of this medication in this population requires careful consideration of risks and benefits.

Statistics and clinical data

drug_classWHO
2023

Drug class

Value:Local anesthetic (amide type)

Prilocaine belongs to the amide local anesthetic class

prescribingWHO
2023

ATC Code

Value:N01BB04

Anatomical Therapeutic Chemical classification code for local anesthetics

usageFDA
2023

Common uses

Value:Local infiltration and nerve block anesthesia in dentistry and minor surgical procedures

Primary therapeutic applications

formulationsFDA
2023

Brand names

Value:Citanest, Relador, Citanest Forte, Oraqix

Available commercial formulations

Prilocaine is used for temporary pain relief during minor medical procedures such as needle insertions, blood draws, vaccinations, and dermatological treatments. It is also applied before cosmetic procedures, tattooing, and laser treatments. Additionally, it may be used to relieve pain associated with minor skin irritations or as part of combination therapies.

Prilocaine works by blocking sodium channels in nerve fibers, preventing the generation and conduction of nerve impulses. When applied topically, it penetrates the epidermal and dermal layers of the skin, accumulating in nerve endings to inhibit pain signals. The onset of action typically occurs within 30-60 minutes of application under an occlusive dressing.

Prilocaine should not be applied to broken or inflamed skin. Caution is needed in patients with methemoglobinemia, glucose-6-phosphate dehydrogenase deficiency, or those taking medications that affect methemoglobin levels. Side effects may include local skin reactions such as redness, pallor, or mild burning sensation at the application site.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy